
Sichuan Kelun-Biotech Biopharmaceutical Investor Relations Material
Latest events

H2 2024
24 Mar, 2025

H1 2024
19 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Access all reports
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a China-based company engaged in the research, development, and manufacturing of biopharmaceutical products. The company focuses on innovative therapeutics across various medical fields, including oncology, infectious diseases, and autoimmune disorders. It develops biologic drugs and biosimilars, utilizing advanced biotechnological platforms to address unmet medical needs. Sichuan Kelun-Biotech serves both domestic and international pharmaceutical markets. The company is headquartered in Chengdu, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd


H2 2024
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd


H2 2024
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
6990
Country
🇭🇰 Hong Kong